Home Product listing Lundbeck publishes listing document relating to new shareholding structure

Lundbeck publishes listing document relating to new shareholding structure

0

Valby, Denmark, May 20, 2022H.Lundbeck A/S (Lundbeck) today announced the publication of a listing document. The registration document is required for the purposes of the proposed new share structure, whereby each of the existing shares of Lundbeck, subject to the approval of the general meeting, will be divided into one (1) A share comprising ten votes and four (4) B Shares each carrying one vote. The Listing Document has been approved by the Danish Financial Supervisory Authority.

The Listing Document and the documents incorporated by reference are posted on Lundbeck’s webpage (https://www.lundbeck.com/global/investors/the-share/new-share-structure).

The dual-share structure – including an expected timetable – is described in more detail in the Listing Document and in the notice convening the extraordinary general meeting to be held. June 8, 2022, 9:30 a.m. (CET)published on May 16, 2022 (see company press release no. 721).

Contact Lundbeck

Investors: Media:
Palle Holm Olesen Thomas Mikkel Mortensen
Vice President, Investor Relations Media Relations Manager Corp. Communication
[email protected] [email protected]
+45 30 83 24 26 +45 30 83 30 24

IMPORTANT INFORMATION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES STATES, Canada, Australia, Japan, India, hong kongSingapore OR South Africa or TO ANY PERSON IN ANY JURISDICTION WHERE RELEASE, PUBLICATION OR DISTRIBUTION TO SUCH PERSON IS RESTRICTED BY ANY APPLICABLE LAW OR REGULATION IN SUCH JURISDICTION.

THIS PRESS RELEASE IS NOT AN OFFER TO SELL OR AN INVITATION TO PURCHASE OR SUBSCRIBE, OR A SOLICITATION OF AN OFFER TO BUY OR SUBSCRIBE, FOR SECURITIES.

THE REGISTRATION DOCUMENT HAS BEEN DRAWN UP SOLELY TO COMPLY WITH LUNDBECK’S OBLIGATIONS UNDER APPLICABLE DANISH SECURITIES LAW AND REGULATIONS TO EFFECT THE SPLIT OF THE SHARES. THE OFFERING DOCUMENT CANNOT BE REFERRED TO FOR ANY PURPOSES OTHER THAN THE SPLITTING OF SHARES.

On H.Lundbeck A/S

Lundbeck is a global pharmaceutical company specializing in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are relentlessly dedicated to restoring brain health, so that everyone can perform at their best. We are committed to fighting stigma and discrimination against people with brain conditions and advocating for wider social acceptance of people with brain conditions. Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline focuses on developing transformative treatments for brain diseases for which there are few or no treatment options.

For more information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Instagram (h_lundbeck), Twitter at @Lundbeck and via LinkedIn.

Third Party Information, Legends, and Safe Harbor/Forward-Looking Statements

This corporate statement may include third-party statements or references to third-party information. To the extent that information from third parties arises directly from this document, the company can confirm that the information has been faithfully reproduced, but the company can give no assurance as to the accuracy of the information or the forward-looking statements contained in these statements. coming. in existence. To the extent that the company makes reference to third party information, including a reference to the Lundbeck Foundation web page, such information should not be considered part of this corporate statement and the company assumes no responsibility for the accuracy of such information.

None of the securities referred to herein have been or will be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of a state or other jurisdiction in United States, and may not be offered, pledged, sold, delivered or otherwise transferred, directly or indirectly, except under an exemption or in a transaction not subject to the registration requirements of the Securities Act securities and in accordance with other applicable securities laws. There will be no public offering of any of the securities of United States.

This corporate news release contains forward-looking statements that provide our expectations or forecasts of future events such as new product introductions, product approvals and financial performance. Forward-looking statements include, but are not limited to, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words such as “believe”, “anticipate”, “expect to”, “estimate”, “intend”, “plan”, “project”, “will”, “continue”, “result”, “could”, “may”, “might”, or any variation of these words or other words with similar meanings. All statements other than statements of historical fact included in this presentation, including, without limitation, those regarding our financial condition, business strategy, management plans and objectives for future operations (including plans for development and objectives relating to our products), are forward-looking statements.

These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that could affect future results include, but are not limited to, interest rate and currency exchange rate fluctuations, delay or failure of development projects, production or distribution problems, breaches of contract or unexpected terminations, government-mandated or market-driven price reductions for Lundbeck’s products, introduction of competing products, Lundbeck’s ability to successfully market new and existing products, exposure to product liability and other lawsuits, changes in reimbursement rules and governmental laws and related interpretation, and unexpected growth in costs and expenses.

Forward-looking statements contained in this document and oral presentations made on behalf of Lundbeck speak only as of the date of this presentation. Lundbeck undertakes no obligation to update or revise any forward-looking statements in this presentation or oral presentations made on behalf of Lundbeck, or to confirm such statements to reflect subsequent events or circumstances after the date of the presentation or in relationship to actual results, unless otherwise required by applicable law or stock exchange regulations.

H.Lundbeck A/S

Ottiliavej 9, 2500 Valby, Denmark

+45 3630 1311

[email protected]

https://news.cision.com/h–lundbeck-as/r/lundbeck-publishes-listing-document-relating-to-the-new-share-structure,c3571387

https://mb.cision.com/Main/18215/3571387/1582566.pdf

(c) Decision 2022. All rights reserved., sources Press Releases – English